Express Pharma

MAY 5, 2024

Phase 1 trial shows 90 per cent recurrence-free survival and 90 per cent complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively Janssen-Cilag International NV, a Johnson & Johnson company, recently updated results from an open-label, multicentre, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted releasing system designed to provide sustained, local release of erdafitinib into the bladder, i

Labelling 84

Labelling 84

Drug Patent Watch

MAY 5, 2024

Annual Drug Patent Expirations for DUAVEE Duavee is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers.

59

59

Pharmacy Joe

MAY 5, 2024

In this episode, I’ll discuss the problem with hypo-osmolar solutions in neurological patients. Episode 919: The problem with hypo-osmolar solutions in neurological patients Subscribe on iTunes , Android , or Stitcher The administration of hypo-osmolar IV solutions causes an increase in water into the brain. This is because an intact blood-brain barrier is permeable to water but not electrolytes.

Hospitals 52

Hospitals Inpatient 52

Express Pharma

MAY 5, 2024

According to the company’s statement, all EIRs are in place for their USFDA facilities After an inspection carried out by the US Food and Drug Administration ( USFDA), Alembic Pharmaceuticals has received its Establishment Inspection Report (EIR) for its oncology (injectable and oral solid) formulation facility. Located at Panelav, the inspection was carried out from February 28 to March 8, 2024.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

RX Note

MAY 5, 2024

Introduction The 7 Habits of Highly Effective People , first published in 1989, is a business and self-help book by Stephen R. Covey. A sequel, titled The 8th Habit: From Effectiveness to Greatness , followed in 2004. Deep Roots for Lasting Solutions Significant problems we face cannot be solved with the same level of thinking that created them. In all of life, there are sequential stages of growth and development.

52

52

Med Ed 101

MAY 5, 2024

Is it safe for women to breastfeed while taking antidepressants? According to a CDC report from 2020, ~10.3% of women ages 18-39 take antidepressants, and the number of people diagnosed with depression and taking antidepressants continues to rise. In this article, we will look at the use of SSRIs in lactation. All antidepressants pass into […] The post SSRIs In Lactation appeared first on Med Ed 101.

52

52

PharmaTech

MAY 5, 2024

Webinar Date/Time: Tue, Jun 4, 2024 9:00 AM EDT

Packaging 52

Packaging 52

Drug Patent Watch

MAY 5, 2024

This chart shows the pharmaceutical companies with the most patents in Hong Kong.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies 95

FDA Law Blog: Biosimilars

MAY 5, 2024

By Larry K. Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance (Apr. 30, 2024).

Controlled Substances 91

Controlled Substances Chemotherapy Dosage Labelling 91